Evidence map›Paper›PMID 42713368›Full record

ArticleFrontiers in medicine2026

The predictive value of preoperative ultrasound contrast parameters for early recurrence after transarterial chemoembolization for hepatocellular carcinoma.

Shuqiang Jin, Qimeihui Wang, Lingyu Zhu, Dengke Teng, Guoqing Sui, Hui Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuqiang JinDepartment of Ultrasound, China-Japan Union Hospital of Jilin University, Jinlin, China.
Qimeihui WangDepartment of Ultrasound, China-Japan Union Hospital of Jilin University, Jinlin, China.
Lingyu ZhuDepartment of Ultrasound, China-Japan Union Hospital of Jilin University, Jinlin, China.
Dengke TengDepartment of Ultrasound, China-Japan Union Hospital of Jilin University, Jinlin, China.
Guoqing SuiDepartment of Ultrasound, China-Japan Union Hospital of Jilin University, Jinlin, China.
Hui WangDepartment of Ultrasound, China-Japan Union Hospital of Jilin University, Jinlin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To analyze the predictive value of preoperative contrast-enhanced ultrasound (CEUS) parameters for early recurrence after transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). Methods: A retrospective study was conducted on 242 HCC patients treated at our hospital between May 2021 and May 2023. Based on recurrence within 24 months post-TACE, patients were categorized into an early recurrence group ( Results: Significant differences were found between the two groups in alpha-fetoprotein (AFP), carbohydrate antigen 199 (CA199), aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transpeptidase (GGT), alkaline phosphatase (ALP), total bilirubin (TBIL), tumor maximum diameter, and rapid washout in the portal phase (all Conclusion: The combined detection of the CEUS parameters TTP, mTT, and PI can effectively assist in predicting early recurrence in HCC patients after TACE.

Indexed as

contrast-enhanced ultrasoundearly recurrenceMTTPItransarterial chemoembolization for hepatocellular carcinomaTTP

Identifiers

PMID42713368
PMCPMC13552009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.